Related Experiment Videos
[Progress of research in osteoarthritis. Molecular targeting for osteoarthritis treatment]
1Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo.
Abstract:
Little is known about molecular mechanism underlying osteoarthrits. Recent mouse genetic approaches by others and us found that the proteinases produced during the endochondral ossification process cause cartilage degradation at the center of the joint and osteophyte formation at the periphery. The difference of the two sites may depend on the vascularity. At the periphery, vascularity is accessible from the synovium or tendon, which completes endochondral ossification and forms osteophytes, just as it does at the embryonic and growth plate cartilage. However, in the center, the vascularity is not accessible from the edge, so that it may end up with cartilage degradation without being replaced by bone. Molecules related to the endochondral ossification will be a therapeutic target of osteoarthritis.
Insights
Osteoarthritis involves proteinases from endochondral ossification, causing cartilage damage centrally and bone spurs peripherally. Targeting these molecules offers a potential osteoarthritis therapy.
Area of Science:
- Molecular Biology
- Orthopedics
- Pathology
Background:
- The molecular mechanisms driving osteoarthritis (OA) remain largely unknown.
- Endochondral ossification (EO) processes are implicated in OA pathogenesis.
- Distinct joint regions exhibit differential responses to EO-related molecular events.
Purpose of the Study:
- To investigate the role of proteinases produced during endochondral ossification in osteoarthritis.
- To elucidate the differential mechanisms of cartilage degradation and osteophyte formation in OA.
- To identify potential molecular therapeutic targets for osteoarthritis.
Main Methods:
- Utilized mouse genetic approaches to study osteoarthritis mechanisms.
- Analyzed the effects of proteinases from endochondral ossification on joint tissues.
- Correlated vascularity differences with site-specific OA pathology.
Main Results:
- Proteinases from endochondral ossification contribute to cartilage degradation at the joint center.
- The same proteinases promote osteophyte formation at the joint periphery.
- Joint vascularity influences whether endochondral ossification leads to bone formation or cartilage degradation.
Conclusions:
- Molecules involved in endochondral ossification are key players in osteoarthritis.
- Differential vascular access dictates site-specific OA outcomes (degradation vs. bone formation).
- Targeting endochondral ossification pathways presents a promising therapeutic strategy for osteoarthritis.
